# Ipamorelin, CJC-1295 and sermorelin

Canonical: https://europeanpeptideshop.com/blog/ipamorelin-vs-cjc-1295-vs-sermorelin/

Explore the catalogue and research library. Ordering and shipping have not opened yet.

Comparisons · 8 November 2026 · 3 min read · By [European Peptide Shop](https://europeanpeptideshop.com/about/)

### On this page

## These names do not identify the same peptide

Ipamorelin, CJC-1295 and Sermorelin appear together in discussions of growth-hormone-related research, but a shared research context does not make them interchangeable. Their sequences, modifications and receptor relationships must be kept separate when interpreting a paper or a product record.

Sermorelin denotes the amidated GHRH/GRF 1–29 fragment, as recorded in the [FDA substance identity database](https://precision.fda.gov/uniisearch/srs/unii/89243s03te). Ipamorelin is a structurally distinct pentapeptide secretagogue. CJC-1295 terminology needs additional care because catalogue descriptions sometimes use “no DAC” for modified GRF 1–29, while the original long-acting CJC-1295 literature concerns an albumin-binding modification.

## What the primary papers actually studied

[Raun and colleagues' 1998 Ipamorelin paper](https://pubmed.ncbi.nlm.nih.gov/9849822/) describes its structure and pharmacology in experimental systems. It is not a study of a mixed commercial vial.

[Jetté and colleagues' 2005 CJC-1295 study](https://pubmed.ncbi.nlm.nih.gov/15817669/) describes modified GRF 1–29 derivatives with an albumin-reactive group and work in cell and rat models. That modification is a defining part of the molecule studied. The [2006 study by Teichman and colleagues](https://pubmed.ncbi.nlm.nih.gov/16352683/) then examined a long-acting CJC-1295 preparation in healthy adults. Its reported persistence cannot be assigned to a no-DAC catalogue material by shortening the name to “CJC”.

These sources identify particular molecules and preparations. They do not establish outcomes, equivalence or administration guidance for the PCUK listing.

## A practical identity comparison

Name on a record | Detail to establish before comparing it

Sermorelin | Exact GHRH fragment and terminal form

Ipamorelin | Compound identity, sequence or reference identifier and supplied form

CJC-1295 with DAC | Whether the albumin-binding modification is explicitly specified

CJC-1295 no DAC | The actual modified GRF identity, without assuming the DAC study preparation

CJC/Ipamorelin blend | Both component identities, their labelled amounts and the combined quantity

The [no-DAC identity guide](https://europeanpeptideshop.com/blog/cjc-1295-dac-no-dac-ipamorelin/) covers the naming issue in more detail. A certificate that says only “CJC/IPA” needs enough additional context to tie its target definitions to the material supplied.

## Reading the PCUK blend listing

The [CJC-1295 no DAC + Ipamorelin 10mg listing](https://europeanpeptideshop.com/shop/cjc-no-dac-ipamorelin-10mg/) describes a combined research material. Read its component specification and report together. The total quantity is not the quantity of each component, and a blend is not the same procurement format as separate vials.

An analytical report should state which components were identified or quantified and how the results are expressed. A single unexplained percentage cannot answer every composition question. The [HPLC guide](https://europeanpeptideshop.com/blog/what-hplc-purity-means/) and [COA guide](https://europeanpeptideshop.com/blog/how-to-read-peptide-coa/) distinguish those measurements. Use the current product page for availability rather than assuming a standalone compound is stocked because it appears in this comparison.

## EPS documentation

Use the [research catalogue](https://europeanpeptideshop.com/shop/) to check the exact name, labelled amount and format. The [COA library](https://europeanpeptideshop.com/coa/) publishes the original Janoshik reports selected for EPS, retaining the original report client name and any missing batch fields. Literature findings and another supplier's analytical results are not evidence about an EPS batch.

## Laboratory research only

Materials listed on this site are supplied for in-vitro laboratory research and are not for use in or on humans or animals. They are not medicines. This article summarises published work and gives no dosing, administration, treatment or in-vivo guidance. Findings from a study apply to the material and conditions of that study, and they say nothing about any product listed here.

## References

- [FDA substance identity database](https://precision.fda.gov/uniisearch/srs/unii/89243s03te)

- [Raun and colleagues' 1998 Ipamorelin paper](https://pubmed.ncbi.nlm.nih.gov/9849822/)

- [Jetté and colleagues' 2005 CJC-1295 study](https://pubmed.ncbi.nlm.nih.gov/15817669/)

- [2006 study by Teichman and colleagues](https://pubmed.ncbi.nlm.nih.gov/16352683/)

## Related listings

 [10 mg](https://europeanpeptideshop.com/shop/ipamorelin-10mg/) 

Growth hormone research

### [Ipamorelin](https://europeanpeptideshop.com/shop/ipamorelin-10mg/)

10 mg · Lyophilised powder

Ordering opens later. Prices and availability are not yet published.[Details](https://europeanpeptideshop.com/shop/ipamorelin-10mg/)

 [10 mg](https://europeanpeptideshop.com/shop/cjc-1295-10mg/) 

Growth hormone research

### [CJC-1295 with DAC](https://europeanpeptideshop.com/shop/cjc-1295-10mg/)

10 mg · Lyophilised powder

Ordering opens later. Prices and availability are not yet published.[Details](https://europeanpeptideshop.com/shop/cjc-1295-10mg/)

 [10 mg](https://europeanpeptideshop.com/shop/sermorelin-acetate-10mg/) 

Growth hormone research

### [Sermorelin Acetate](https://europeanpeptideshop.com/shop/sermorelin-acetate-10mg/)

10 mg · Lyophilised powder

Ordering opens later. Prices and availability are not yet published.[Details](https://europeanpeptideshop.com/shop/sermorelin-acetate-10mg/)

## More articles

Comparisons · 4 min read

## [CJC-1295: DAC, no DAC and blends](https://europeanpeptideshop.com/blog/cjc-1295-dac-no-dac-ipamorelin/)

Compare standalone CJC-1295 with DAC, no DAC and Ipamorelin with a two-ingredient blend. Check the exact listing, component amounts and report.

8 November 2026

Compound research · 3 min read

## [Ipamorelin structure and mechanism](https://europeanpeptideshop.com/blog/ipamorelin-research/)

Explore ipamorelin’s pentapeptide sequence, D-amino acids, terminal amide and ghrelin-receptor mechanism, with primary pharmacology and human PK/PD sources.

8 November 2026

Buying guides · 3 min read

## [CJC-1295 and ipamorelin blend prices](https://europeanpeptideshop.com/blog/cjc-ipamorelin-vial-prices/)

Compare cjc-1295 and ipamorelin blend prices, labelled amounts and documentation. See EPS format details and what to check before comparing final EUR quotes.

8 November 2026
